Electrocardiographic identification of drug effects: QT prolongation, arrhythmias, and clinical monitoring
A systematic narrative review of drug-induced ECG changes, QTc measurement methodology, TdP risk stratification, and ECG monitoring protocols covering January 2006 to April 2026 found evidence that evidence-based monitoring protocols, correction of modifiable risk factors, and prompt recognition of ominous ECG patterns...